Atlas Trials

Randomized CT to Evaluate Efficacy of Neoadjuvant Chemotherapy Customized by Levels of BRCA1-HER2 Negative Breast Cancer

Clinical trial NCT02365805 · COMPLETED

Trial details

NCT number
NCT02365805
Sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2014-04-01
Primary completion
2016-10-10
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.